DE2845762A1 - Heilmittel mit antiviraler wirkung - Google Patents

Heilmittel mit antiviraler wirkung

Info

Publication number
DE2845762A1
DE2845762A1 DE19782845762 DE2845762A DE2845762A1 DE 2845762 A1 DE2845762 A1 DE 2845762A1 DE 19782845762 DE19782845762 DE 19782845762 DE 2845762 A DE2845762 A DE 2845762A DE 2845762 A1 DE2845762 A1 DE 2845762A1
Authority
DE
Germany
Prior art keywords
adenine
dhpa
formula
arabinofuranosyl
dihydroxypropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19782845762
Other languages
German (de)
English (en)
Other versions
DE2845762C2 (da
Inventor
Erik Prof Dr Declercq
Antonin Dr Holy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Rega VZW
Czech Academy of Sciences CAS
Original Assignee
Stichting Rega VZW
Czech Academy of Sciences CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega VZW, Czech Academy of Sciences CAS filed Critical Stichting Rega VZW
Publication of DE2845762A1 publication Critical patent/DE2845762A1/de
Application granted granted Critical
Publication of DE2845762C2 publication Critical patent/DE2845762C2/de
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE19782845762 1977-10-20 1978-10-20 Heilmittel mit antiviraler wirkung Granted DE2845762A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS776839A CS199093B1 (en) 1977-10-20 1977-10-20 Antiviral agent

Publications (2)

Publication Number Publication Date
DE2845762A1 true DE2845762A1 (de) 1979-04-26
DE2845762C2 DE2845762C2 (da) 1987-05-27

Family

ID=5416334

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782845762 Granted DE2845762A1 (de) 1977-10-20 1978-10-20 Heilmittel mit antiviraler wirkung

Country Status (4)

Country Link
JP (1) JPS5480427A (da)
CH (1) CH642543A5 (da)
CS (2) CS199093B1 (da)
DE (1) DE2845762A1 (da)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530142A1 (fr) * 1982-07-08 1984-01-20 Yamasa Shoyu Kk Composition contenant un agent renforcant les effets antitumoraux, et medicament comprenant une substance antitumorale et un tel agent
US4495190A (en) * 1980-12-22 1985-01-22 Astra Lakemedel Aktiebolag Derivatives of guanine for combating herpes virus infections

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6455001U (da) * 1987-10-01 1989-04-05

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495190A (en) * 1980-12-22 1985-01-22 Astra Lakemedel Aktiebolag Derivatives of guanine for combating herpes virus infections
FR2530142A1 (fr) * 1982-07-08 1984-01-20 Yamasa Shoyu Kk Composition contenant un agent renforcant les effets antitumoraux, et medicament comprenant une substance antitumorale et un tel agent

Also Published As

Publication number Publication date
JPS5480427A (en) 1979-06-27
CS199093B1 (en) 1980-07-31
CH642543A5 (en) 1984-04-30
JPS6140206B2 (da) 1986-09-08
DE2845762C2 (da) 1987-05-27
CS199095B1 (en) 1980-07-31

Similar Documents

Publication Publication Date Title
DE3687069T2 (de) Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
DE69206876T2 (de) Nukleosidanalogen enthaltende Antiviren-Zubereitungen
DE69413529T2 (de) Antivirale verbindungen
DE2728685A1 (de) Arzneimittel
DE69313872T2 (de) Verbindung von nucleocidanaloga zur behandlung viraler infektionen
EP0040325B1 (de) Verwendung von Adenosinderivaten zur Herstellung eines Psychopharmakons
EP0409227A2 (de) Pyrimidinnucleoside, ihre Herstellung und pharmazeutische Mittel
DD146049A5 (de) Verfahren zur herstellung von komplexverbindungen von 9-hydroxyalkyl-purinen
CH678726A5 (da)
DE3873207T2 (de) Antivirale therapie gegen hepatitis b mit 2',3'-didesoxynucleosiden.
EP0355031A2 (de) Substituierte Pyrimidinnucleoside, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
DE3879688T2 (de) Anti-retrovirales arzneimittel.
JP2724711B2 (ja) 医薬品生成物
DE69923338T2 (de) Kombinationstherapie zur behandlung von hepatitis b infektionen
DE1695976B2 (de) 4-Hydroxy-l- ß -D-ribofuranosyl- tetrahydro-2 (lH)-pyrimidinon, Verfahren zu seiner Herstellung und seine Verwendung
EP0374096A1 (de) 2',3'-Dideoxypurinnucleosid/Purinnucleosid-Phosphorylase-Inhibitor Kombinationstherapie und Zusammensetzungen dafür
DE2823346C2 (de) Verwendung von Glycinderivaten zur Herstellung von antiviriellen Mitteln
DE1949813A1 (de) Substituierte Pyrazole
CH621333A5 (da)
DE2845762A1 (de) Heilmittel mit antiviraler wirkung
DE2538573A1 (de) Uridine und diese enthaltende pharmazeutische praeparate
DD261094A5 (de) Verwendung der verbindung 1-beta-d-ribofuranosyl-1,2,4,-triazol-3-carbonsaeureamid zur herstellung einer pharmazeutischen zusammensetzung
DE3141970C2 (da)
DE2305553A1 (de) Arzneimittel zur behandlung von virusinfektionen
DE2618223C2 (da)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition